GCMG
BSX icon

Gyroscope Capital Management Group’s Boston Scientific BSX Stock Holding History

Gyroscope Capital Management Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$298K Buy
5,648
+648
+13% +$34K 0.07% 161
2023
Q2 		$270K Buy
+5,000
New +$261K 0.06% 152

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gyroscope Capital Management Group's BSX Position: Q3 2023 in Review

Gyroscope Capital Management Group increased its Boston Scientific (BSX) stake by 13% in Q3 2023, buying an estimated $34K and bringing the position to 5,648 shares worth $298K. The position accounts for 0.07% of the portfolio, ranked #161.

Gyroscope Capital Management Group first reported a position in BSX in Q2 2023 and has held it in 2 quarters since. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Gyroscope Capital Management Group held 5,648 shares of Boston Scientific worth $298K as of Q3 2023.
  • Gyroscope Capital Management Group bought 648 Boston Scientific shares in Q3 2023, an estimated $34K.
  • Boston Scientific made up 0.07% of Gyroscope Capital Management Group's portfolio in Q3 2023, its #161 holding.
  • Gyroscope Capital Management Group first reported a position in Boston Scientific in Q2 2023 and has held it in 2 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2023, filed 13 Nov 2023.